A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：BIOMARKER RESEARCH ISSN： 2050-7771 出版频率： Continuous publication 出版社： BMC, CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW   出版社网址： https://www.biomedcentral.com/ 期刊网址： https://biomarkerres.biomedcentral.com/ 影响因子： 6.148 主题范畴： ONCOLOGY;    MEDICINE, RESEARCH & EXPERIMENTAL 变更情况： Newly Added by 2019 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Aims and scope Biomarker Research is an open access, peer-reviewed journal that encompasses all aspects of biomarker investigation. Biomarker Research aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines. The study of biomarkers has evolved rapidly in the advance of personalized medicine and individual health. The identification and validation of biomarkers in drug discovery/development and in disease diagnosis, treatment, prognosis, and prevention play an essential role in the genome era. With a quick turnaround time from submission to publication and online feedback from readers, Biomarker Research strives to provide fast dissemination of novel findings and new knowledge. Open access All articles published by Biomarker Research are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here. As authors of articles published in Biomarker Research you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement. For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed. Article-processing charges Open access publishing is not without costs. Biomarker Research therefore levies an article-processing charge of £1870.00/$2680.00/€2170.00 for each article accepted for publication, plus VAT or local taxes where applicable. If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page. BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service. Indexing services All articles published in Biomarker Research are included in: DOAJ  Embase  PubMed PubMed Central SCImago Science Citation Index Expanded Scopus Zetoc The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BMC on SpringerLink. Peer-review policy Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here. Biomarker Research operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript. Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board. Editorial policies All manuscripts submitted to Biomarker Research should adhere to BioMed Central's editorial policies. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Instructions to Authors Our 3-step submission process   Before you submit Now you’ve identified a journal to submit to, there are a few things you should be familiar with before you submit. Make sure you are submitting to the most suitable journal - Aims and scope Understand the costs and funding options - Fees and funding Make sure your manuscript is accurate and readable - Language editing services Understand the copyright agreement - Copyright   Ready to submit To give your manuscript the best chance of publication, follow these policies and formatting guidelines. General formatting rules for all article types - Preparing your manuscript Make sure your submission is complete - Prepare supporting information Copyright and license agreement - Conditions of publication Read and agree to our Editorial Policies - Editorial policies   Submit and promote After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond. Please note that manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.  Who decides whether my work will be accepted? - Peer-review policy Want to submit to a different journal? - Manuscript transfers Spreading the word - Promoting your publication Submit manuscript Editorial Board Editors-in-Chief Chung-Tsen Hsueh, Loma Linda University, USA  Delong Liu, New York Medical College, USA  Section Editors Gary G Xiao, Creighton University, USA Zhizhuang J Zhao, University of Oklahoma, USA Yi Zhang, First Affiliated Hospital of Zhengzhou University, China Associate Editors Pilar Garrido, Hospital Universitario Ramón y Cajal, Spain  Jens Kastrup Rigshospitalet, Copenhagen University Hospital, Denmark Tony Mok, The Chinese University of Hong Kong, Hong Kong Fernando Vidal-Vanaclocha, CEU San Pablo University and HM-Hospitals School of Medicine, Spain  Yu-Jui Yvonne Wan, University of California Davis Health Systems, USA Hong Wang, Temple University School of Medicine, USA   Editorial Board Christoph Bergmann, University Hospital Essen, Germany  Hong Chang, University of Toronto, Canada  Chih-Hwa Chen, Taipei Medical University, Taiwan  Jeon-Hor Chen, University of California Irvine, USA Tao Cheng, Chinese Academy of Medical Sciences, China  Hua-Hong (Ben) Chien, The Ohio State University, USA Wei Dai, New York University, USA  Rajat Deo, University of Pennsylvania, USA  Y Peter Di, University of Pittsburgh, USA  Thomas Efferth, Johannes Gutenberg University, Germany Bevin Gangadharan, University of Oxford, UK  Onn Hashim, University of Malaya, Malaysia  Noboru Hattori, Hiroshima University, Japan  Karen Heichman, University of Utah, USA  Joanna Holbrook, Singapore Institute for Clinical Sciences, Singapore Ping-I Hsu, Kaohsiung Veterans General Hospital, Taiwan   John P A Ioannidis, Stanford University, USA  Jingfang Ju, Stony Brook University Medical Center, USA Nobuyuki Koyama, Saitama Medical University, Japan  Prakash Kulkarni, Johns Hopkins University, USA Hsien-Yuan Lane, China Medical University and Hospital, Taiwan  Caroline G L Lee, National University of Singapore, Singapore  Shaoguang Li, University of Massachusetts Medical School, USA  Saied Mirshahidi, Loma Linda University, USA  Jen-Jung Pan, University of Arizona College of Medicine Tucson, USA Ondrej Slaby, Masaryk Memorial Cancer Institute, Czech Republic  Egbert F Smit Vrije, Universiteit Medical Centre, The Netherlands  Jianmin Wang, Changhai Hospital of The Second Military Medical University, China  Xin Wang, Provincial Hospital Affiliated to Shandong University, China  Shenhong Wu, Stony Brook University School of Medicine, USA  Rui-hua Xu,  Sun Yat-sen University, China  Timothy Yap, The Institute of Cancer Research, UK  Hung-I Yeh, Mackay Medical College, Taiwan Go Yoshida, Tokyo Medical and Dental University, Japan George Yousef, University of Toronto, Canada  Ruirong Yuan, University of Medicine and Denistry of New Jersey, USA Hua Zhang, Guangdong Medical University, China  Jianying Zhang, The University of Texas at El Paso, USA  Weili Zhao, Shanghai Jiaotong University, China  Jian Zhou, Fudan University, China